BASEPOINT
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

BASEPOINT Trademark

Serial Number: 88870009

BASEPOINT is a trademark filed by ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANY on April 13, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANY (27 trademarks)

70 SIR JOHN ROGERSON'S QUAY
DUBLIN 2 , IE

Entity Type: 79

Trademark Details

Filing Date

April 13, 2020

Registration Date

Not Registered

Published for Opposition

May 25, 2021

Goods & Services

Medical diagnostic test kits comprised of medical diagnostic reagents for testing bodily fluids for use in detecting, diagnosing, screening, and confirming infectious disease, respiratory infection, pregnancy, ovulation, cardiovascular disease, hospital acquired infection, blood borne pathogens, enterics, vector borne pathogens, sexually transmitted infection, tropical disease infection, cancer, drugs, and alcohol; medical diagnostic test strips for use in detecting, diagnosing, screening, and confirming infectious disease, respiratory infection, pregnancy, ovulation, cardiovascular disease, hospital acquired infection, blood borne pathogens, enterics, vector borne pathogens, sexually transmitted infection, tropical disease infection, cancer, drugs, and alcohol; medical diagnostic reagents; diagnostic preparations for medical purposes; testing preparations for medical use, namely, for testing for infectious disease, respiratory infection, pregnancy, ovulation, cardiovascular disease, hospital acquired infection, blood borne pathogens, enterics, vector borne pathogens, sexually transmitted infection, tropical disease infection, cancer, drugs, and alcohol; diagnostic tests in the nature of reagents and assays for testing of body fluids for medical use; medical diagnostic assays; solutions used in medical diagnostic test kits, namely, solutions for medical and clinical use in testing for infectious disease, respiratory infection, pregnancy, ovulation, cardiovascular disease, hospital acquired infection, blood borne pathogens, enterics, vector borne pathogens, sexually transmitted infection, tropical disease infection, cancer, drugs, and alcohol; cartridges containing reagents for medical diagnostic test use; cartridges containing medical diagnostic reagents; test cartridges containing chemical reagents for in vitro diagnostic medical testing; medical reagents contained in a cartridge for medical diagnostic use; in vitro diagnostic reagents contained in pre-filled cartridges for medical use; medical diagnostics tests for the detection, diagnosis, screening, and confirmation of infectious diseases; medical kits comprising reagents and assays for testing for the presence of antigens in blood, human serum, plasma, urine, other biological fluids, and tissue; chromatographic immunoassay tests for medical use; testing kits comprised of medical diagnostic reagents and assays for detecting alcohol and drugs; drug and alcohol testing panels, namely, medical diagnostic reagents and assays for testing bodily fluids for the presence of drugs and alcohol

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 22, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 21, 2022 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 20, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 25, 2021 NPUB
PUBLISHED FOR OPPOSITION
May 25, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 5, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 20, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 7, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 7, 2021 CRFA
ASSIGNED TO LIE
Apr 6, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 6, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 6, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jul 6, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jul 6, 2020 CNRT
ASSIGNED TO EXAMINER
Jun 29, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 21, 2020 NWOS
NEW APPLICATION ENTERED
Apr 16, 2020 NWAP